Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Baker Cummins Dermatologicals was a pharmaceutical company specializing in the development and marketing of topical treatments for various skin and scalp conditions. The company was widely recognized for its portfolio of dermatological products, including brands such as P&S Liquid, X-Seb shampoo, and Ultra Mide 25, which were used to treat psoriasis, seborrheic dermatitis, and severe dry skin. Originally operating as a division of Key Pharmaceuticals, it later became part of Baker Norton Pharmaceuticals under the Ivax Corporation umbrella. The company's legacy products were eventually integrated into Teva Pharmaceutical Industries following its acquisition of Ivax.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Baker Cummins Dermatologicals.